1993 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 1 Similar Profiles
Autoimmune Experimental Myasthenia Gravis Medicine & Life Sciences
Cholinergic Receptors Medicine & Life Sciences
Duchenne Muscular Dystrophy Medicine & Life Sciences
Epitopes Medicine & Life Sciences
Torpedo Medicine & Life Sciences
Intranasal Administration Medicine & Life Sciences
Muscles Medicine & Life Sciences
Artificial Receptors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2006 2020

Glycogen Storage Disease Type II
Enzyme Replacement Therapy
Prospective Studies
Late Onset Disorders

Muscular Dystrophy Center Lab Day

Karachunski, P. I.

Biogen IDEC

2/8/1812/31/18

Project: Research project

Duchenne Muscular Dystrophy
Nonsense Codon
Inpatients
Placebos
Safety
Glycogen Storage Disease Type II
Safety
Therapeutics
Late Onset Disorders
human GAA protein

Research Output 1993 2018

1 Citations

A multinational study on motor function in early-onset FSHD

Mah, J. K., Feng, J., Jacobs, M. B., Duong, T., Carroll, K., De Valle, K., Carty, C. L., Morgenroth, L. P., Guglieri, M., Ryan, M. M., Clemens, P. R., Thangarajh, M., Webster, R., Smith, E., Connolly, A. M., McDonald, C. M., Karachunski, P., Tulinius, M., Harper, A., Cnaan, A. & 1 othersChen, Y. W., Apr 10 2018, In : Neurology. 90, 15, p. e1333-e1338

Research output: Contribution to journalArticle

Facioscapulohumeral Muscular Dystrophy
Age of Onset
Muscles
Linear Models
Disease Progression

The diagnostic approach to the hypotonic and weak infant

Karachunski, P. I., Jan 1 2018, Clinical Handbook of Neuromuscular Medicine. Springer International Publishing, p. 113-132 20 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Spinal Muscular Atrophy
Myotonia Congenita
Muscle Hypotonia
Muscular Dystrophies
Genetic Testing

Xanthine oxidase is hyper-active in Duchenne muscular dystrophy

Lindsay, A., McCourt, P. M., Karachunski, P. I., Lowe, D. A. & Ervasti, J. M., Dec 1 2018, In : Free Radical Biology and Medicine. 129, p. 364-371 8 p.

Research output: Contribution to journalArticle

Duchenne Muscular Dystrophy
Xanthine Oxidase
Inbred mdx Mouse
Dystrophin
Muscle
35 Citations

Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Clinical Evaluator Training Group, Sep 23 2017, In : The Lancet. 390, 10101, p. 1489-1498 10 p.

Research output: Contribution to journalArticle

Duchenne Muscular Dystrophy
Nonsense Codon
Placebos
Dystrophin
Factor IX
3 Citations

De novo, deleterious sequence variants that alter the transcriptional activity of the homeoprotein PBX1 are associated with intellectual disability and pleiotropic developmental defects

Slavotinek, A., Risolino, M., Losa, M., Cho, M. T., Monaghan, K. G., Schneidman-Duhovny, D., Parisotto, S., Herkert, J. C., Stegmann, A. P. A., Miller, K., Shur, N., Chui, J., Muller, E., DeBrosse, S., Szot, J. O., Chapman, G., Pachter, N. S., Winlaw, D. S., Mendelsohn, B. A., Dalton, J. & 7 othersSarafoglou, K., Karachunski, P. I., Lewis, J. M., Pedro, H., Dunwoodie, S. L., Selleri, L. & Shieh, J., Dec 1 2017, In : Human molecular genetics. 26, 24, p. 4849-4860 12 p.

Research output: Contribution to journalArticle

Homeodomain Proteins
Intellectual Disability
Branchial Region
Amino Acids
Genes